TY - GEN
T1 - Correction to
T2 - Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program
AU - Simpson, Eric L
AU - Silverberg, Jonathan I
AU - Nosbaum, Audrey
AU - Winthrop, Kevin L
AU - Guttman-Yassky, Emma
AU - Hoffmeister, Karin M
AU - Egeberg, Alexander
AU - Valdez, Hernan
AU - Zhang, Min
AU - Farooqui, Saleem A
AU - Romero, William
AU - Thorpe, Andrew J
AU - Rojo, Ricardo
AU - Johnson, Susan
PY - 2021/11
Y1 - 2021/11
N2 - SpringerLink on 18 August 2021. After publication in volume 22, issue 5, pages 693–707, the authors highlighted that, in Supplemental Table 1, the overall patient numbers for the JADE MONO-2 and JADE COMPARE studies were incorrect. These errors have been rectified and a new corrected version of Supplementary file 1 has been uploaded with the manuscript on SpringerLink. The original article has been corrected.
AB - SpringerLink on 18 August 2021. After publication in volume 22, issue 5, pages 693–707, the authors highlighted that, in Supplemental Table 1, the overall patient numbers for the JADE MONO-2 and JADE COMPARE studies were incorrect. These errors have been rectified and a new corrected version of Supplementary file 1 has been uploaded with the manuscript on SpringerLink. The original article has been corrected.
U2 - 10.1007/s40257-021-00638-z
DO - 10.1007/s40257-021-00638-z
M3 - Other contribution
C2 - 34642878
VL - 22
T3 - American Journal of Clinical Dermatology
ER -